data_1ulo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ulo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.313 0.578 . . . . 4.64 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -129.96 97.11 24.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 4.74 110.127 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.4 -156.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.021 1.537 . . . . 2.86 110.202 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.461 ' CD1' HG13 ' A' ' 144' ' ' VAL . 6.6 pt -116.98 43.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 1.29 110.252 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 71.67 68.35 1.63 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.385 -1.486 . . . . 1.88 109.385 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.8 tt0 -42.08 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -1.11 . . . . 2.91 110.335 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 159.39 -163.48 33.47 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.717 -1.353 . . . . 2.38 109.717 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.457 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 12.8 p -92.93 -141.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -1.066 . . . . 2.73 110.215 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 36.8 m-85 -126.67 44.4 2.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 2.21 109.787 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.1 p-10 -84.35 45.81 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 2.71 110.586 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-20 161.67 44.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.559 -0.713 . . . . 2.76 109.965 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.17 142.36 10.5 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.5 -1.44 . . . . 1.3 109.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 52.0 Cg_endo -79.45 13.01 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.038 1.547 . . . . 1.18 111.025 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 3.9 tp10 63.07 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.258 -0.901 . . . . 2.8 110.542 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 17' ' ' VAL . . . -135.65 1.64 3.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.946 -1.262 . . . . 0.71 109.946 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.573 ' CE2' HD23 ' A' ' 49' ' ' LEU . 56.7 m95 -57.97 119.53 6.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -1.183 . . . . 0.65 110.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -120.95 147.94 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.935 . . . . 1.18 109.904 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.83 148.39 52.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.221 -0.924 . . . . 1.16 109.251 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -142.07 164.71 29.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 2.18 110.808 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 21' ' ' THR . . . 79.96 34.17 31.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.021 -1.232 . . . . 1.8 110.021 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.55 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 12.0 p -148.28 -156.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -1.226 . . . . 3.42 110.465 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.7 t70 -90.31 119.17 30.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 3.93 109.976 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 47.16 -169.85 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.383 -1.487 . . . . 2.11 109.383 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.26 -158.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.023 1.538 . . . . 2.51 110.309 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -102.2 159.02 15.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.209 -0.932 . . . . 1.94 109.777 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.05 140.47 50.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 2.45 110.751 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -124.55 -83.58 0.64 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.411 -0.806 . . . . 1.37 109.648 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.1 OUTLIER 35.51 54.12 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.671 -0.643 . . . . 2.32 111.127 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 28' ' ' SER . 14.6 t -177.74 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.156 -0.965 . . . . 3.58 110.326 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 9' ' ' PHE . . . 122.66 16.66 3.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.692 -1.363 . . . . 1.61 109.692 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . . . -149.65 132.93 16.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.22 . . . . 1.25 110.361 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -77.68 100.62 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 1.22 109.946 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.6 m -107.1 107.49 18.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.93 110.62 -179.611 -77.757 -69.009 132.547 104.258 2.02 104.24 -85.447 -78.474 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' OG1' ' A' ' 138' ' ' THR . 28.7 m -99.26 147.26 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 1.13 109.966 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -90.1 98.54 11.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.28 110.704 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 78.6 t -81.99 133.41 51.51 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.308 -0.87 . . . . 1.12 109.808 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HD2' HG11 ' A' ' 36' ' ' VAL . 39.8 Cg_endo -67.61 171.11 12.47 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.946 1.498 . . . . 0.92 111.626 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 40' ' ' SER . . . -57.32 123.57 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.514 -0.742 . . . . 1.5 111.354 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.62 24.52 0.08 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.845 -0.902 . . . . 1.68 110.845 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.615 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 31.0 t 25.32 56.69 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 118.171 0.986 . . . . 2.26 110.539 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.63 97.96 11.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.463 -0.773 . . . . 2.49 110.25 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 1.7 pt20 171.27 -157.98 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.746 -0.464 . . . . 3.05 109.746 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.2 p90 -42.42 -26.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 3.24 110.03 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 112.82 129.46 5.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.0 -1.24 . . . . 1.06 110.0 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.615 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 11.3 t -89.29 172.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.085 -1.244 . . . . 1.23 108.772 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' HA2' ' HG ' ' A' ' 129' ' ' LEU . . . 176.23 -178.3 47.65 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.986 -1.578 . . . . 0.67 110.888 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 25.1 t -151.21 127.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.483 -0.932 . . . . 1.1 108.483 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.505 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 36.0 m -122.77 142.55 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.108 . . . . 1.15 111.338 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -133.82 94.59 3.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.458 -0.776 . . . . 1.37 110.051 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 18.2 p30 -77.46 142.4 39.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 3.06 110.412 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.63 60.31 0.13 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.859 -1.297 . . . . 0.72 109.859 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 39.8 t -120.24 165.17 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -1.181 . . . . 1.2 110.102 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' N ' HG11 ' A' ' 52' ' ' VAL . . . -130.24 79.13 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.172 -0.955 . . . . 1.45 110.855 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.583 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 44.6 mm -110.1 161.13 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 1.18 109.49 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 10.5 tt0 -155.76 132.41 10.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 2.45 110.842 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 57' ' ' GLY . 14.0 pt-20 36.75 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 1.84 111.073 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.492 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -85.24 80.15 1.84 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.725 -1.35 . . . . 0.72 109.725 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.565 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -108.68 170.64 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 1.22 109.681 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.78 156.55 18.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 1.4 110.161 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.583 ' CZ ' HD11 ' A' ' 54' ' ' ILE . 62.4 m-85 -159.37 148.8 18.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 2.28 110.178 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 115.59 23.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 1.19 110.08 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.8 tp -89.7 122.74 33.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 1.28 109.954 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 1.8 ttp180 -125.14 118.12 25.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 3.33 110.522 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.556 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 1.2 p90 -158.25 143.35 16.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.877 . . . . 2.03 110.13 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 27.7 m -119.32 97.92 5.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 1.22 109.562 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB3' HD21 ' A' ' 141' ' ' LEU . . . -97.93 151.63 20.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 1.06 110.639 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 97.4 m -150.28 109.88 4.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.378 -0.826 . . . . 1.16 110.008 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.01 133.65 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 1.14 110.136 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -44.99 -26.39 0.42 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 1.65 109.348 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.539 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.9 t -111.92 172.69 6.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.525 -0.734 . . . . 1.36 109.801 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.3 t70 -88.67 60.99 5.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 1.93 109.423 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 137' ' ' TRP . 5.9 p -82.89 141.2 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.838 . . . . 1.11 111.146 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.2 m -124.01 90.37 3.25 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.677 -0.86 . . . . 1.2 108.677 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.4 m -91.19 -148.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 1.14 110.25 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.514 ' N ' HG21 ' A' ' 74' ' ' VAL . 4.4 mtm180 -132.46 138.31 47.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.94 . . . . 3.9 110.489 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -138.31 151.59 47.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 1.09 109.571 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.1 pp 179.82 -149.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 1.18 110.446 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.562 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.7 t -150.57 168.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 1.08 109.353 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.535 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -175.36 -165.2 31.13 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.144 -1.503 . . . . 0.54 110.479 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' CG ' ' O ' ' A' ' 122' ' ' GLU . 33.9 tt0 -117.63 138.05 52.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.955 . . . . 2.41 110.374 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.6 m120 -92.76 90.63 7.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 2.15 109.859 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 122.09 145.47 7.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.47 -1.452 . . . . 1.86 109.47 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . -49.46 157.22 0.96 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 2.08 110.358 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -79.04 12.6 18.3 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.574 -2.261 . . . . 2.05 110.902 -0.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.3 153.26 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 2.82 110.046 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.77 113.33 0.39 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.436 . . . . 0.93 109.509 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.47 143.58 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -1.13 . . . . 1.22 110.179 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 18.5 m -119.94 -19.68 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 1.26 110.064 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.577 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -116.19 144.4 44.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.858 . . . . 1.13 110.838 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.02 80.28 1.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 2.28 110.1 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 p -142.86 174.42 10.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.923 -1.111 . . . . 1.25 110.979 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -119.75 114.25 34.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 1.44 109.895 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 42.7 Cg_endo -70.92 102.24 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.982 1.517 . . . . 0.56 111.317 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -74.89 149.36 39.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.16 -0.962 . . . . 1.11 109.112 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.529 HD11 ' CG1' ' A' ' 72' ' ' VAL . 49.8 mt -136.07 166.66 22.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 1.29 110.735 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.95 -178.88 5.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.424 -0.797 . . . . 1.31 110.035 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.33 -5.48 23.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 1.82 110.215 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' O ' HG21 ' A' ' 67' ' ' THR . 2.7 mt-10 -108.77 171.1 4.77 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 2.09 110.119 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.5 Cg_endo -72.82 130.04 15.18 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.59 110.402 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.72 92.18 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 2.51 110.31 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 2.4 mt-30 -73.68 153.18 40.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 2.52 109.927 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.556 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 84.3 t -136.24 131.97 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 1.24 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 112.75 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 1.32 110.025 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.46 157.85 43.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 2.05 110.49 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 m -114.19 104.49 12.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 2.04 109.998 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.577 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 39.3 p90 -109.24 153.67 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 2.24 110.424 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -92.79 97.01 10.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 1.36 109.901 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -57.11 104.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 1.05 110.423 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 97.5 p -92.16 52.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 1.2 110.127 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.91 -156.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 1.13 110.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 55' ' ' GLU . 20.8 m -150.94 113.95 4.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.94 . . . . 1.35 110.453 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.574 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.6 m-30 -111.18 85.81 5.73 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 2.22 109.706 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.9 Cg_endo -70.96 138.27 33.65 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.887 1.467 . . . . 1.06 110.406 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.39 55.81 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 1.71 110.362 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.72 91.17 6.19 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 2.98 110.227 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.58 109.81 2.85 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.062 1.559 . . . . 2.12 110.338 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 120' ' ' ASP . . . -136.15 -171.38 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 2.5 110.211 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.51 42.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 3.37 110.283 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 2.7 t70 -111.79 -22.33 11.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 4.3 110.297 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.401 ' HB2' ' HB1' ' A' ' 117' ' ' ALA . 2.4 m-20 -102.66 100.85 17.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 3.46 110.275 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.72 -159.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.955 1.503 . . . . 3.22 110.398 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.508 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -154.46 -140.31 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.908 . . . . 2.1 110.416 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -162.0 150.96 20.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.91 -1.676 . . . . 0.73 108.91 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.541 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.4 pt20 -150.35 -157.88 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 2.21 110.85 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.473 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 9.0 mt -118.07 142.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.915 -0.772 . . . . 1.14 108.915 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.06 122.0 43.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.61 -0.836 . . . . 1.17 111.486 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.48 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.83 92.74 3.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.258 -1.386 . . . . 2.18 107.258 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 7.0 mt-30 -87.6 114.69 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.905 -1.122 . . . . 2.58 112.247 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 10.2 mt -111.19 43.28 1.5 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.179 -1.045 . . . . 1.18 108.179 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.19 107.38 3.44 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.261 -1.136 . . . . 0.98 110.261 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.92 87.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.856 -1.298 . . . . 1.15 109.856 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.584 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.4 m-85 -145.61 -61.73 0.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 2.27 110.481 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.554 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -88.9 179.75 6.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.95 -1.094 . . . . 1.22 110.306 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.85 -85.1 0.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 1.59 109.986 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.82 171.13 11.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 1.46 109.982 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.456 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -58.69 135.64 57.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 1.25 110.734 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.629 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 10.8 p90 -141.99 -159.15 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.57 109.806 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.488 HG21 ' N ' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -160.37 170.7 20.5 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.997 -1.081 . . . . 1.48 110.841 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.488 ' N ' HG21 ' A' ' 138' ' ' THR . 2.3 mp -126.77 130.53 50.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.532 -0.73 . . . . 1.13 109.112 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 32.8 m -127.41 96.61 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.88 111.473 -179.102 -78.474 -85.447 132.547 104.24 2.02 104.258 -69.009 -77.757 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -90.21 -176.01 4.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 1.11 109.001 178.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 3.2 p30 171.04 46.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 1.67 110.723 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER 169.69 70.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.231 -0.918 . . . . 1.94 109.462 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.549 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.6 t -104.97 116.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 1.31 110.623 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.32 27.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 1.26 109.918 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.4 tp -131.35 131.11 43.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.882 . . . . 1.29 110.328 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -155.22 158.55 39.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 1.82 110.296 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' THR . 31.4 p -95.24 150.23 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.47 110.1 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -62.08 94.27 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 3.76 110.494 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 150' ' ' VAL . 7.2 p -108.2 20.73 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 5.56 110.0 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 151' ' ' GLU . 2.4 pp20? -99.85 120.07 39.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.461 -0.775 . . . . 8.26 110.475 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.505 ' C ' ' CD1' ' A' ' 152' ' ' LEU . 1.2 tm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 10.2 109.875 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.313 0.578 . . . . 4.2000000000000002 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -129.96 97.11 24.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 4.4900000000000002 110.127 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.4 -156.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.021 1.537 . . . . 2.27 110.202 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 144' ' ' VAL . 6.6 pt -116.98 43.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 1.29 110.252 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 71.67 68.35 1.63 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.385 -1.486 . . . . 1.8 109.385 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.8 tt0 -42.08 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -1.11 . . . . 2.9100000000000001 110.335 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 159.39 -163.48 33.47 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.717 -1.353 . . . . 1.8500000000000001 109.717 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.632 HG22 ' OD2' ' A' ' 143' ' ' ASP . 12.8 p -92.93 -141.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -1.066 . . . . 2.3999999999999999 110.215 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.548 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 36.8 m-85 -126.67 44.4 2.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 1.9199999999999999 109.787 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.1 p-10 -84.35 45.81 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 2.71 110.586 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-20 161.67 44.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.559 -0.713 . . . . 2.7599999999999998 109.965 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.17 142.36 10.5 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.5 -1.44 . . . . 1.0 109.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.681 ' HB3' HD12 ' A' ' 32' ' ' LEU . 52.0 Cg_endo -79.45 13.01 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.038 1.547 . . . . 1.0800000000000001 111.025 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 3.9 tp10 63.07 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.258 -0.901 . . . . 2.7999999999999998 110.542 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -135.65 1.64 3.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.946 -1.262 . . . . 0.59999999999999998 109.946 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.861 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 56.7 m95 -57.97 119.53 6.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -1.183 . . . . 0.65000000000000002 110.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -120.95 147.94 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.935 . . . . 0.51000000000000001 109.904 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.83 148.39 52.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.221 -0.924 . . . . 0.56999999999999995 109.251 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.675 ' HE2' HG13 ' A' ' 48' ' ' VAL . 21.2 p90 -142.07 164.71 29.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 1.3200000000000001 110.808 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 79.96 34.17 31.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.021 -1.232 . . . . 1.8 110.021 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.55 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 12.0 p -148.28 -156.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -1.226 . . . . 2.9700000000000002 110.465 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.7 t70 -90.31 119.17 30.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 3.9300000000000002 109.976 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 47.16 -169.85 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.383 -1.487 . . . . 1.6599999999999999 109.383 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.26 -158.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.023 1.538 . . . . 2.0600000000000001 110.309 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.796 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -102.2 159.02 15.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.209 -0.932 . . . . 1.3200000000000001 109.777 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.05 140.47 50.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 2.4500000000000002 110.751 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 29' ' ' THR . 1.0 OUTLIER -124.55 -83.58 0.64 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.411 -0.806 . . . . 1.3500000000000001 109.648 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.1 OUTLIER 35.51 54.12 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.671 -0.643 . . . . 2.0600000000000001 111.127 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 27' ' ' THR . 14.6 t -177.74 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.156 -0.965 . . . . 3.1499999999999999 110.326 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 29' ' ' THR . . . 122.66 16.66 3.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.692 -1.363 . . . . 1.3100000000000001 109.692 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . . . -149.65 132.93 16.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.22 . . . . 0.81999999999999995 110.361 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD11 ' CD1' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -77.68 100.62 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.56000000000000005 109.946 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.6 m -107.1 107.49 18.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.93000000000000005 110.62 -179.611 -77.757 -69.009 132.547 104.258 2.02 104.24 -85.447 -78.474 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 25' ' ' LEU . 28.7 m -99.26 147.26 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.45000000000000001 109.966 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -90.1 98.54 11.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.76000000000000001 110.704 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 78.6 t -81.99 133.41 51.51 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.308 -0.87 . . . . 0.46999999999999997 109.808 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.8 Cg_endo -67.61 171.11 12.47 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.946 1.498 . . . . 0.79000000000000004 111.626 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 40' ' ' SER . . . -57.32 123.57 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.514 -0.742 . . . . 1.1000000000000001 111.354 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.62 24.52 0.08 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.845 -0.902 . . . . 1.6799999999999999 110.845 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.972 ' OG ' HG23 ' A' ' 45' ' ' VAL . 31.0 t 25.32 56.69 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 118.171 0.986 . . . . 1.79 110.539 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.63 97.96 11.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.463 -0.773 . . . . 2.2200000000000002 110.25 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 1.7 pt20 171.27 -157.98 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.746 -0.464 . . . . 2.73 109.746 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.2 p90 -42.42 -26.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 2.9100000000000001 110.03 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 112.82 129.46 5.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.0 -1.24 . . . . 0.82999999999999996 110.0 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.972 HG23 ' OG ' ' A' ' 40' ' ' SER . 11.3 t -89.29 172.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.085 -1.244 . . . . 0.76000000000000001 108.772 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.504 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 176.23 -178.3 47.65 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.986 -1.578 . . . . 0.67000000000000004 110.888 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 17' ' ' VAL . 25.1 t -151.21 127.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.483 -0.932 . . . . 0.42999999999999999 108.483 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG13 ' HE2' ' A' ' 19' ' ' TYR . 36.0 m -122.77 142.55 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.108 . . . . 0.46999999999999997 111.338 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.603 HD22 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -133.82 94.59 3.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.458 -0.776 . . . . 0.62 110.051 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.5 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 18.2 p30 -77.46 142.4 39.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 2.3300000000000001 110.412 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.63 60.31 0.13 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.859 -1.297 . . . . 0.71999999999999997 109.859 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 39.8 t -120.24 165.17 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -1.181 . . . . 0.69999999999999996 110.102 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -130.24 79.13 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.172 -0.955 . . . . 0.92000000000000004 110.855 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.593 HG13 ' CD2' ' A' ' 112' ' ' TYR . 44.6 mm -110.1 161.13 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.77000000000000002 109.49 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' HA ' HG23 ' A' ' 111' ' ' THR . 10.5 tt0 -155.76 132.41 10.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 2.4500000000000002 110.842 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' GLU . 14.0 pt-20 36.75 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 1.8400000000000001 111.073 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -85.24 80.15 1.84 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.725 -1.35 . . . . 0.71999999999999997 109.725 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -108.68 170.64 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.78000000000000003 109.681 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.78 156.55 18.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.73999999999999999 110.161 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 58' ' ' THR . 62.4 m-85 -159.37 148.8 18.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 1.3799999999999999 110.178 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 88.9 m -120.81 115.59 23.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.52000000000000002 110.08 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.8 tp -89.7 122.74 33.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.56000000000000005 109.954 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 1.8 ttp180 -125.14 118.12 25.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 2.8500000000000001 110.522 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.876 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 1.2 p90 -158.25 143.35 16.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.877 . . . . 1.1699999999999999 110.13 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 27.7 m -119.32 97.92 5.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.47999999999999998 109.562 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.744 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.93 151.63 20.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.29999999999999999 110.639 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 98' ' ' GLU . 97.4 m -150.28 109.88 4.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.378 -0.826 . . . . 0.40000000000000002 110.008 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -99.01 133.65 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.45000000000000001 110.136 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -44.99 -26.39 0.42 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 1.26 109.348 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -111.92 172.69 6.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.525 -0.734 . . . . 1.3600000000000001 109.801 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.3 t70 -88.67 60.99 5.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 1.9299999999999999 109.423 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.9 p -82.89 141.2 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.838 . . . . 0.40000000000000002 111.146 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.2 m -124.01 90.37 3.25 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.677 -0.86 . . . . 0.5 108.677 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.592 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.4 m -91.19 -148.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 110.25 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 mtm180 -132.46 138.31 47.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.94 . . . . 3.25 110.489 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -138.31 151.59 47.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.40000000000000002 109.571 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.1 pp 179.82 -149.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.46000000000000002 110.446 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.837 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.7 t -150.57 168.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.41999999999999998 109.353 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -175.36 -165.2 31.13 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.144 -1.503 . . . . 0.44 110.479 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 85' ' ' TYR . 33.9 tt0 -117.63 138.05 52.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.955 . . . . 2.3300000000000001 110.374 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.6 m120 -92.76 90.63 7.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 1.71 109.859 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 122.09 145.47 7.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.47 -1.452 . . . . 1.8600000000000001 109.47 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . -49.46 157.22 0.96 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 1.6599999999999999 110.358 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -79.04 12.6 18.3 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.574 -2.261 . . . . 1.8500000000000001 110.902 -0.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.539 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.3 153.26 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 2.04 110.046 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.77 113.33 0.39 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.436 . . . . 0.91000000000000003 109.509 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.47 143.58 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -1.13 . . . . 0.64000000000000001 110.179 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.748 HG23 ' CD1' ' A' ' 89' ' ' LEU . 18.5 m -119.94 -19.68 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.56999999999999995 110.064 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.754 HD11 ' CE2' ' A' ' 106' ' ' PHE . 4.2 mp -116.19 144.4 44.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.858 . . . . 0.38 110.838 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.02 80.28 1.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 2.2799999999999998 110.1 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 p -142.86 174.42 10.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.923 -1.111 . . . . 0.60999999999999999 110.979 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.9 m -119.75 114.25 34.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.94999999999999996 109.895 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.715 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 42.7 Cg_endo -70.92 102.24 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.982 1.517 . . . . 0.56000000000000005 111.317 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -74.89 149.36 39.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.16 -0.962 . . . . 0.46999999999999997 109.112 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.744 HD21 ' CB ' ' A' ' 66' ' ' ALA . 49.8 mt -136.07 166.66 22.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.54000000000000004 110.735 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.95 -178.88 5.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.424 -0.797 . . . . 0.73999999999999999 110.035 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.33 -5.48 23.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 1.3799999999999999 110.215 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 67' ' ' THR . 2.7 mt-10 -108.77 171.1 4.77 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 2.0899999999999999 110.119 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.5 Cg_endo -72.82 130.04 15.18 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.56000000000000005 110.402 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.72 92.18 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 1.99 110.31 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.496 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 2.4 mt-30 -73.68 153.18 40.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 2.3199999999999998 109.927 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.876 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 84.3 t -136.24 131.97 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.60999999999999999 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 112.75 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.68999999999999995 110.025 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 61' ' ' THR . 6.0 mt-10 -145.46 157.85 43.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 2.0499999999999998 110.49 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 m -114.19 104.49 12.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 1.4099999999999999 109.998 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.754 ' CE2' HD11 ' A' ' 89' ' ' LEU . 39.3 p90 -109.24 153.67 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 1.3300000000000001 110.424 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -92.79 97.01 10.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.80000000000000004 109.901 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -57.11 104.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.48999999999999999 110.423 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.469 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 97.5 p -92.16 52.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.68999999999999995 110.127 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.91 -156.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.46999999999999997 110.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 55' ' ' GLU . 20.8 m -150.94 113.95 4.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.94 . . . . 0.72999999999999998 110.453 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.6 m-30 -111.18 85.81 5.73 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 1.3300000000000001 109.706 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.9 Cg_endo -70.96 138.27 33.65 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.887 1.467 . . . . 1.0600000000000001 110.406 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.39 55.81 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 1.3799999999999999 110.362 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.72 91.17 6.19 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 2.52 110.227 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.58 109.81 2.85 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.062 1.559 . . . . 2.1200000000000001 110.338 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -136.15 -171.38 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 2.5 110.211 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.51 42.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 2.9900000000000002 110.283 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 2.7 t70 -111.79 -22.33 11.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 4.2999999999999998 110.297 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 2.4 m-20 -102.66 100.85 17.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 3.46 110.275 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.49 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.72 -159.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.955 1.503 . . . . 2.7999999999999998 110.398 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.508 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -154.46 -140.31 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.908 . . . . 2.1000000000000001 110.416 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -162.0 150.96 20.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.91 -1.676 . . . . 0.52000000000000002 108.91 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.579 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.4 pt20 -150.35 -157.88 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 1.72 110.85 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.507 HG21 ' CH2' ' A' ' 16' ' ' TRP . 9.0 mt -118.07 142.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.915 -0.772 . . . . 0.51000000000000001 108.915 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.06 122.0 43.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.61 -0.836 . . . . 0.34999999999999998 111.486 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.83 92.74 3.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.258 -1.386 . . . . 1.28 107.258 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.475 ' C ' HD23 ' A' ' 129' ' ' LEU . 7.0 mt-30 -87.6 114.69 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.905 -1.122 . . . . 2.02 112.247 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 139' ' ' LEU . 10.2 mt -111.19 43.28 1.5 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.179 -1.045 . . . . 0.65000000000000002 108.179 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.19 107.38 3.44 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.261 -1.136 . . . . 0.97999999999999998 110.261 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.92 87.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.856 -1.298 . . . . 0.93999999999999995 109.856 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.4 m-85 -145.61 -61.73 0.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 1.3799999999999999 110.481 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.701 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.9 179.75 6.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.95 -1.094 . . . . 0.85999999999999999 110.306 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.85 -85.1 0.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 1.02 109.986 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.82 171.13 11.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 1.46 109.982 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.436 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -58.69 135.64 57.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.64000000000000001 110.734 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.089 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 10.8 p90 -141.99 -159.15 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.46999999999999997 109.806 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -160.37 170.7 20.5 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.997 -1.081 . . . . 0.77000000000000002 110.841 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -126.77 130.53 50.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.532 -0.73 . . . . 0.68000000000000005 109.112 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 32.8 m -127.41 96.61 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.88 111.473 -179.102 -78.474 -85.447 132.547 104.24 2.02 104.258 -69.009 -77.757 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -90.21 -176.01 4.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.53000000000000003 109.001 178.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 p30 171.04 46.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 1.6699999999999999 110.723 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.632 ' OD2' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER 169.69 70.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.231 -0.918 . . . . 1.9399999999999999 109.462 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.6 t -104.97 116.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.64000000000000001 110.623 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.32 27.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 0.48999999999999999 109.918 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 54' ' ' ILE . 38.4 tp -131.35 131.11 43.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.882 . . . . 0.78000000000000003 110.328 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -155.22 158.55 39.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 1.8200000000000001 110.296 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' THR . 31.4 p -95.24 150.23 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.28 110.1 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -62.08 94.27 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 3.7599999999999998 110.494 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.2 p -108.2 20.73 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 5.1100000000000003 110.0 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 151' ' ' GLU . 2.4 pp20? -99.85 120.07 39.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.461 -0.775 . . . . 8.2599999999999998 110.475 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.791 ' C ' HD13 ' A' ' 152' ' ' LEU . 1.2 tm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 9.8599999999999994 109.875 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.313 0.578 . . . . 4.2000000000000002 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -129.96 97.11 24.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 4.4900000000000002 110.127 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.4 -156.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.021 1.537 . . . . 2.27 110.202 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 144' ' ' VAL . 6.6 pt -116.98 43.33 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 1.29 110.252 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 71.67 68.35 1.63 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.385 -1.486 . . . . 1.8 109.385 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.8 tt0 -42.08 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -1.11 . . . . 2.9100000000000001 110.335 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 159.39 -163.48 33.47 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.717 -1.353 . . . . 1.8500000000000001 109.717 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.632 HG22 ' OD2' ' A' ' 143' ' ' ASP . 12.8 p -92.93 -141.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -1.066 . . . . 2.3999999999999999 110.215 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.548 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 36.8 m-85 -126.67 44.4 2.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 1.9199999999999999 109.787 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.1 p-10 -84.35 45.81 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 2.71 110.586 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-20 161.67 44.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.559 -0.713 . . . . 2.7599999999999998 109.965 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.17 142.36 10.5 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.5 -1.44 . . . . 1.0 109.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.681 ' HB3' HD12 ' A' ' 32' ' ' LEU . 52.0 Cg_endo -79.45 13.01 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.038 1.547 . . . . 1.0800000000000001 111.025 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 3.9 tp10 63.07 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.258 -0.901 . . . . 2.7999999999999998 110.542 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -135.65 1.64 3.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.946 -1.262 . . . . 0.59999999999999998 109.946 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.861 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 56.7 m95 -57.97 119.53 6.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -1.183 . . . . 0.65000000000000002 110.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -120.95 147.94 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.935 . . . . 0.51000000000000001 109.904 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.83 148.39 52.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.221 -0.924 . . . . 0.56999999999999995 109.251 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.675 ' HE2' HG13 ' A' ' 48' ' ' VAL . 21.2 p90 -142.07 164.71 29.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 1.3200000000000001 110.808 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 79.96 34.17 31.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.021 -1.232 . . . . 1.8 110.021 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.55 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 12.0 p -148.28 -156.65 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -1.226 . . . . 2.9700000000000002 110.465 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.7 t70 -90.31 119.17 30.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -0.84 . . . . 3.9300000000000002 109.976 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 47.16 -169.85 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.383 -1.487 . . . . 1.6599999999999999 109.383 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.26 -158.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.023 1.538 . . . . 2.0600000000000001 110.309 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.796 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -102.2 159.02 15.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.209 -0.932 . . . . 1.3200000000000001 109.777 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -120.05 140.47 50.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 2.4500000000000002 110.751 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 29' ' ' THR . 1.0 OUTLIER -124.55 -83.58 0.64 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.411 -0.806 . . . . 1.3500000000000001 109.648 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.1 OUTLIER 35.51 54.12 0.82 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.671 -0.643 . . . . 2.0600000000000001 111.127 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 27' ' ' THR . 14.6 t -177.74 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.156 -0.965 . . . . 3.1499999999999999 110.326 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 29' ' ' THR . . . 122.66 16.66 3.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.692 -1.363 . . . . 1.3100000000000001 109.692 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . . . -149.65 132.93 16.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.22 . . . . 0.81999999999999995 110.361 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD11 ' CD1' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -77.68 100.62 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.56000000000000005 109.946 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.6 m -107.1 107.49 18.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.93000000000000005 110.62 -179.611 -77.757 -69.009 132.547 104.258 2.02 104.24 -85.447 -78.474 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 25' ' ' LEU . 28.7 m -99.26 147.26 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.45000000000000001 109.966 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -90.1 98.54 11.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.76000000000000001 110.704 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 78.6 t -81.99 133.41 51.51 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.308 -0.87 . . . . 0.46999999999999997 109.808 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.8 Cg_endo -67.61 171.11 12.47 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.946 1.498 . . . . 0.79000000000000004 111.626 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 40' ' ' SER . . . -57.32 123.57 15.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.514 -0.742 . . . . 1.1000000000000001 111.354 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.62 24.52 0.08 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.845 -0.902 . . . . 1.6799999999999999 110.845 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.972 ' OG ' HG23 ' A' ' 45' ' ' VAL . 31.0 t 25.32 56.69 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 118.171 0.986 . . . . 1.79 110.539 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.63 97.96 11.49 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.463 -0.773 . . . . 2.2200000000000002 110.25 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 1.7 pt20 171.27 -157.98 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.746 -0.464 . . . . 2.73 109.746 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.2 p90 -42.42 -26.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 2.9100000000000001 110.03 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 112.82 129.46 5.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.0 -1.24 . . . . 0.82999999999999996 110.0 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.972 HG23 ' OG ' ' A' ' 40' ' ' SER . 11.3 t -89.29 172.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.085 -1.244 . . . . 0.76000000000000001 108.772 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.504 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 176.23 -178.3 47.65 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.986 -1.578 . . . . 0.67000000000000004 110.888 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 17' ' ' VAL . 25.1 t -151.21 127.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.483 -0.932 . . . . 0.42999999999999999 108.483 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG13 ' HE2' ' A' ' 19' ' ' TYR . 36.0 m -122.77 142.55 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.108 . . . . 0.46999999999999997 111.338 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.603 HD22 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -133.82 94.59 3.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.458 -0.776 . . . . 0.62 110.051 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.5 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 18.2 p30 -77.46 142.4 39.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 2.3300000000000001 110.412 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.63 60.31 0.13 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.859 -1.297 . . . . 0.71999999999999997 109.859 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 39.8 t -120.24 165.17 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -1.181 . . . . 0.69999999999999996 110.102 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -130.24 79.13 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.172 -0.955 . . . . 0.92000000000000004 110.855 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.593 HG13 ' CD2' ' A' ' 112' ' ' TYR . 44.6 mm -110.1 161.13 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.77000000000000002 109.49 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' HA ' HG23 ' A' ' 111' ' ' THR . 10.5 tt0 -155.76 132.41 10.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 2.4500000000000002 110.842 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' GLU . 14.0 pt-20 36.75 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 1.8400000000000001 111.073 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -85.24 80.15 1.84 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.725 -1.35 . . . . 0.71999999999999997 109.725 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -108.68 170.64 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.78000000000000003 109.681 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.78 156.55 18.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.73999999999999999 110.161 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 58' ' ' THR . 62.4 m-85 -159.37 148.8 18.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 1.3799999999999999 110.178 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 88.9 m -120.81 115.59 23.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.52000000000000002 110.08 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.8 tp -89.7 122.74 33.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.56000000000000005 109.954 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 1.8 ttp180 -125.14 118.12 25.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 2.8500000000000001 110.522 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.876 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 1.2 p90 -158.25 143.35 16.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.877 . . . . 1.1699999999999999 110.13 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 27.7 m -119.32 97.92 5.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.47999999999999998 109.562 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.744 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.93 151.63 20.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.29999999999999999 110.639 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 98' ' ' GLU . 97.4 m -150.28 109.88 4.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.378 -0.826 . . . . 0.40000000000000002 110.008 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -99.01 133.65 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.45000000000000001 110.136 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -44.99 -26.39 0.42 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 1.26 109.348 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -111.92 172.69 6.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.525 -0.734 . . . . 1.3600000000000001 109.801 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.3 t70 -88.67 60.99 5.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 1.9299999999999999 109.423 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.9 p -82.89 141.2 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.838 . . . . 0.40000000000000002 111.146 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.2 m -124.01 90.37 3.25 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.677 -0.86 . . . . 0.5 108.677 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.592 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.4 m -91.19 -148.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 110.25 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 mtm180 -132.46 138.31 47.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.94 . . . . 3.25 110.489 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -138.31 151.59 47.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.40000000000000002 109.571 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.1 pp 179.82 -149.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.46000000000000002 110.446 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.837 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.7 t -150.57 168.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.41999999999999998 109.353 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -175.36 -165.2 31.13 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.144 -1.503 . . . . 0.44 110.479 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 85' ' ' TYR . 33.9 tt0 -117.63 138.05 52.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.955 . . . . 2.3300000000000001 110.374 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.6 m120 -92.76 90.63 7.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 1.71 109.859 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 122.09 145.47 7.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.47 -1.452 . . . . 1.8600000000000001 109.47 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . -49.46 157.22 0.96 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 1.6599999999999999 110.358 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -79.04 12.6 18.3 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.574 -2.261 . . . . 1.8500000000000001 110.902 -0.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.539 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.3 153.26 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 2.04 110.046 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.77 113.33 0.39 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.436 . . . . 0.91000000000000003 109.509 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.47 143.58 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -1.13 . . . . 0.64000000000000001 110.179 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.748 HG23 ' CD1' ' A' ' 89' ' ' LEU . 18.5 m -119.94 -19.68 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.56999999999999995 110.064 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.754 HD11 ' CE2' ' A' ' 106' ' ' PHE . 4.2 mp -116.19 144.4 44.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.858 . . . . 0.38 110.838 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.02 80.28 1.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 2.2799999999999998 110.1 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 p -142.86 174.42 10.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.923 -1.111 . . . . 0.60999999999999999 110.979 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.9 m -119.75 114.25 34.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.94999999999999996 109.895 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.715 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 42.7 Cg_endo -70.92 102.24 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.982 1.517 . . . . 0.56000000000000005 111.317 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -74.89 149.36 39.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.16 -0.962 . . . . 0.46999999999999997 109.112 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.744 HD21 ' CB ' ' A' ' 66' ' ' ALA . 49.8 mt -136.07 166.66 22.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.54000000000000004 110.735 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -164.95 -178.88 5.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.424 -0.797 . . . . 0.73999999999999999 110.035 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.33 -5.48 23.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 1.3799999999999999 110.215 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 67' ' ' THR . 2.7 mt-10 -108.77 171.1 4.77 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 2.0899999999999999 110.119 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.5 Cg_endo -72.82 130.04 15.18 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.56000000000000005 110.402 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.72 92.18 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 1.99 110.31 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.496 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 2.4 mt-30 -73.68 153.18 40.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 2.3199999999999998 109.927 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.876 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 84.3 t -136.24 131.97 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.60999999999999999 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.93 112.75 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.68999999999999995 110.025 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 61' ' ' THR . 6.0 mt-10 -145.46 157.85 43.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 2.0499999999999998 110.49 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 m -114.19 104.49 12.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 1.4099999999999999 109.998 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.754 ' CE2' HD11 ' A' ' 89' ' ' LEU . 39.3 p90 -109.24 153.67 23.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 1.3300000000000001 110.424 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -92.79 97.01 10.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.80000000000000004 109.901 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -57.11 104.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.48999999999999999 110.423 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.469 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 97.5 p -92.16 52.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.68999999999999995 110.127 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.91 -156.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.46999999999999997 110.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 55' ' ' GLU . 20.8 m -150.94 113.95 4.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.94 . . . . 0.72999999999999998 110.453 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.593 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.6 m-30 -111.18 85.81 5.73 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 1.3300000000000001 109.706 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.9 Cg_endo -70.96 138.27 33.65 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.887 1.467 . . . . 1.0600000000000001 110.406 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.39 55.81 3.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 1.3799999999999999 110.362 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.72 91.17 6.19 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 2.52 110.227 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.58 109.81 2.85 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.062 1.559 . . . . 2.1200000000000001 110.338 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -136.15 -171.38 2.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 2.5 110.211 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.51 42.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 2.9900000000000002 110.283 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 2.7 t70 -111.79 -22.33 11.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 4.2999999999999998 110.297 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 2.4 m-20 -102.66 100.85 17.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 3.46 110.275 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.49 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.72 -159.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.955 1.503 . . . . 2.7999999999999998 110.398 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.508 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -154.46 -140.31 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.908 . . . . 2.1000000000000001 110.416 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -162.0 150.96 20.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.91 -1.676 . . . . 0.52000000000000002 108.91 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.579 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.4 pt20 -150.35 -157.88 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 1.72 110.85 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.507 HG21 ' CH2' ' A' ' 16' ' ' TRP . 9.0 mt -118.07 142.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.915 -0.772 . . . . 0.51000000000000001 108.915 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.06 122.0 43.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.61 -0.836 . . . . 0.34999999999999998 111.486 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.83 92.74 3.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.258 -1.386 . . . . 1.28 107.258 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.475 ' C ' HD23 ' A' ' 129' ' ' LEU . 7.0 mt-30 -87.6 114.69 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.905 -1.122 . . . . 2.02 112.247 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 139' ' ' LEU . 10.2 mt -111.19 43.28 1.5 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.179 -1.045 . . . . 0.65000000000000002 108.179 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.19 107.38 3.44 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.261 -1.136 . . . . 0.97999999999999998 110.261 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.92 87.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.856 -1.298 . . . . 0.93999999999999995 109.856 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.4 m-85 -145.61 -61.73 0.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 1.3799999999999999 110.481 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.701 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.9 179.75 6.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.95 -1.094 . . . . 0.85999999999999999 110.306 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.85 -85.1 0.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 1.02 109.986 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.82 171.13 11.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 1.46 109.982 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.436 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -58.69 135.64 57.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.64000000000000001 110.734 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.089 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 10.8 p90 -141.99 -159.15 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.46999999999999997 109.806 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -160.37 170.7 20.5 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.997 -1.081 . . . . 0.77000000000000002 110.841 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -126.77 130.53 50.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.532 -0.73 . . . . 0.68000000000000005 109.112 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 32.8 m -127.41 96.61 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.963 -1.085 . . . . 0.88 111.473 -179.102 -78.474 -85.447 132.547 104.24 2.02 104.258 -69.009 -77.757 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -90.21 -176.01 4.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.53000000000000003 109.001 178.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 p30 171.04 46.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 1.6699999999999999 110.723 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.632 ' OD2' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER 169.69 70.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.231 -0.918 . . . . 1.9399999999999999 109.462 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.6 t -104.97 116.54 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.64000000000000001 110.623 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.32 27.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 0.48999999999999999 109.918 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 54' ' ' ILE . 38.4 tp -131.35 131.11 43.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.882 . . . . 0.78000000000000003 110.328 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -155.22 158.55 39.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 1.8200000000000001 110.296 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' THR . 31.4 p -95.24 150.23 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.28 110.1 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -62.08 94.27 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 3.7599999999999998 110.494 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.2 p -108.2 20.73 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 5.1100000000000003 110.0 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 151' ' ' GLU . 2.4 pp20? -99.85 120.07 39.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.461 -0.775 . . . . 8.2599999999999998 110.475 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.791 ' C ' HD13 ' A' ' 152' ' ' LEU . 1.2 tm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 9.8599999999999994 109.875 179.815 . . . . . . . . 1 1 . 1 stop_ save_